Furthermore, TRIM28 has been found to facilitate gastric cancer cell proliferation by the serum response factor/Indoleamine 2,3-dioxygenase (SRF/IDO1) axis, whereby it regulates IDO1 expression by modulating SRF levels. This evidence concerns the gene SRF and gastric cancer.